Cargando…
Novel targeted drugs approved by the NMPA and FDA in 2019
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205905/ https://www.ncbi.nlm.nih.gov/pubmed/32385226 http://dx.doi.org/10.1038/s41392-020-0164-4 |
_version_ | 1783530326936518656 |
---|---|
author | Wang, Wenjing Sun, Qiu |
author_facet | Wang, Wenjing Sun, Qiu |
author_sort | Wang, Wenjing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7205905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72059052020-05-08 Novel targeted drugs approved by the NMPA and FDA in 2019 Wang, Wenjing Sun, Qiu Signal Transduct Target Ther Editorial Nature Publishing Group UK 2020-05-08 /pmc/articles/PMC7205905/ /pubmed/32385226 http://dx.doi.org/10.1038/s41392-020-0164-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Editorial Wang, Wenjing Sun, Qiu Novel targeted drugs approved by the NMPA and FDA in 2019 |
title | Novel targeted drugs approved by the NMPA and FDA in 2019 |
title_full | Novel targeted drugs approved by the NMPA and FDA in 2019 |
title_fullStr | Novel targeted drugs approved by the NMPA and FDA in 2019 |
title_full_unstemmed | Novel targeted drugs approved by the NMPA and FDA in 2019 |
title_short | Novel targeted drugs approved by the NMPA and FDA in 2019 |
title_sort | novel targeted drugs approved by the nmpa and fda in 2019 |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205905/ https://www.ncbi.nlm.nih.gov/pubmed/32385226 http://dx.doi.org/10.1038/s41392-020-0164-4 |
work_keys_str_mv | AT wangwenjing noveltargeteddrugsapprovedbythenmpaandfdain2019 AT sunqiu noveltargeteddrugsapprovedbythenmpaandfdain2019 |